BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Galactosylceramidase

Below is an extended Galactosylceramidase patents listing. Click here to return to the Galactosylceramidase main in depth entry.

Patents :

US Patent No.Title
5981835 Transgenic plants as an alternative source of lignocellulosic-degrading enzymes
6787321 Mammalian two-hybrid system for screening for modulators of the accumulation of metabolic products
6797265 Deleted adenovirus vectors and methods of making and administering the same
6818803 Transgenic plants as an alternative source of lignocellulosic-degrading enzymes
6852544 Rapid quantitative analysis of proteins or protein function in complex mixtures
6858425 Human acid alpha glucosidase gene and bovine alpha-S1 casein gene sequences
6867036 Gene expression by positive feedback activation of a cell type-specific promoter
6905827 Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
6939862 Method for transferring nucleic acid into striated muscles
6946126 Replicating adenovirus vectors
7018628 Vectors derived from baculovirus and use for transferring nucleic acids into nerve cells of vertebrates
6730297 Use of recombinant gene delivery vectors for treating or preventing lysosomal storage disorders
6706867 DNA array sequence selection
6670194 Rapid quantitative analysis of proteins or protein function in complex mixtures
6005004 Lipophilic-polycationic delivery systems
6066626 Compositions and method for treating lysosomal storage disease
6083725 Tranfected human cells expressing human .alpha.-galactosidase A protein
6118045 Lysosomal proteins produced in the milk of transgenic animals
6303300 Poly (organo) phosphazenes for use in synthetic transfection systems
6328958 Deleted adenovirus vectors and methods of making and administering the same
6395884 Therapy for .alpha.-galactosidase a deficiency
6472212 Methods and compositions for genetically modifying primate bone marrow cells
6528315 Method for transferring nucleic acid into multicelled eukaryotic organism cells and combination therefor
6566099 Nucleic acid encoding a chimeric polypeptide
7026121 Methods and compositions for diagnosing and monitoring transplant rejection
7034010 Use of recombinant gene delivery vectors for treating or preventing lysosomal storage disorders
7276475 Remodeling and glycoconjugation of peptides
7297511 Interferon alpha: remodeling and glycoconjugation of interferon alpha
7329422 Pharmaceutical compositions
7351410 Treatment of Pompe's disease
7358086 Mammalian two-hybrid system for screening for modulators of the accumulation of metabolic products
7361481 Diagnosis of lysosomal storage disorders using saposins and other markers
7378231 Diagnosis of lysosomal storage disorders using saposins and other markers
7396811 Subcellular targeting of therapeutic proteins
7399613 Sialic acid nucleotide sugars
7402308 Method of delivering genes to the central nervous system of a mammal
7265085 Glycoconjugation methods and proteins/peptides produced by the methods
7265084 Glycopegylation methods and proteins/peptides produced by the methods
7235358 Methods and compositions for diagnosing and monitoring transplant rejection
7115391 Production of recombinant AAV using adenovirus comprising AAV rep/cap genes
7122354 Nucleic acid encoding a chimeric polypeptide
7125843 Glycoconjugates including more than one peptide
7138371 Remodeling and glycoconjugation of peptides
7157277 Factor VIII remodeling and glycoconjugation of Factor VIII
7173003 Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
7179617 Factor IX: remolding and glycoconjugation of Factor IX
7198776 Metal complex compounds
7214660 Erythropoietin: remodeling and glycoconjugation of erythropoietin
7226903 Interferon beta: remodeling and glycoconjugation of interferon beta
7416858 Pharmaceutical compositions of glycoconjugates
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional